Jon P. Stonehouse
2020
In 2020, Jon P. Stonehouse earned a total compensation of $6M as President, Chief Executive Officer and Director at BioCryst Pharmaceuticals, a 164% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $531,094 |
|---|---|
| Option Awards | $4,916,022 |
| Salary | $566,500 |
| Other | $21,325 |
| Total | $6,034,941 |
Stonehouse received $4.9M in option awards, accounting for 81% of the total pay in 2020.
Stonehouse also received $531.1K in non-equity incentive plan, $566.5K in salary and $21.3K in other compensation.
Rankings
In 2020, Jon P. Stonehouse's compensation ranked 1,721st out of 13,090 executives tracked by ExecPay. In other words, Stonehouse earned more than 86.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,721 out of 13,090 | 87th |
Division Manufacturing | 656 out of 5,621 | 88th |
Major group Chemicals And Allied Products | 236 out of 2,254 | 90th |
Industry group Drugs | 197 out of 1,954 | 90th |
Industry Biological Products, Except Diagnostic Substances | 59 out of 411 | 86th |
Source: SEC filing on April 25, 2022.
Stonehouse's colleagues
We found four more compensation records of executives who worked with Jon P. Stonehouse at BioCryst Pharmaceuticals in 2020.